Systematic Review and Meta-Analysis of Haemostatic and Biliostatic Efficacy of Fibrin Sealants in Elective Liver Surgery

Journal of Gastrointestinal Surgery

Volumn 17, Issue 4, 2013, Pages 829-836

  Sanjay, Pandanaboyana ^a   Watt, David G ^b   Wigmore, Stephen J ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

Bile; Fibrin sealant; Haemorrhage; Liver

Indexed keywords

EID: 84875053797     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-012-2055-7     Document Type: Article

References (37)

1. Belghiti J, Hiramatsu K, Benoist S. Seven hundred forty-seven hepatectomies in the 1990's: an update to evaluate the actual risk of liver resection.
2. Yamashita Y, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, Shimada M, Sugimachi K. Bile leakage after hepatic resection. Ann Surg. 2001 Jan; 233(1): 45-50.
3. Ito H, Are C, Gonen M, D'Angelica M, Dematteo RP, Kemeny NE, Fong Y, Blumgart LH, Jarnagin WR. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg. 2008 Jun; 247(6): 994-1002.
4. Raccuia JS, Simonian G, Dardik M, et al. Comparative efficacy of topical hemostatic agents in rat kidney model. Am J Surg. 1992; 163: 234-238.
5. Cobden R, Thrasher E, Harris WH. Topical haemostatic agents to reduce bleeding from cancerous bone: a comparison of microcrystalline collagen, thrombin and thrombin soaked gelatin foam. J Bone Joint Surg Am. 1976; 58: 70 -73.
6. Morgenstern L, Michel SL, Austin E. Control of hepatic bleeding with microfibrillar collagen. Arch Surg. 1977; 12: 941-943.
7. Wakasugi J, Shimada H. Application of fibrin sealant in liver surgery. Biomed Proc. 1994; 43: 2274 -2283.
8. Carless PA, Anthony DM, Henry DA. Systematic review of the use of fibrin sealant to minimize perioperative allogenic blood transfusion. Br J Surg. 2002; 89: 695-703.
9. Lo CM, Fan ST, Liu CL, et al. Biliary complications after hepatic resection. Arch Surg. 1998; 133: 156 -161.
10. Higgins JPT, Green S (eds). Cochrane handbook for systematic reviews of interventions version 5. 0. 0 (updated February 2008). http://www. cochrane-handbook. org [accessed 20. 07. 11].
11. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1e12.
12. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13.
13. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177e88.
14. Demets DL. Methods for combining randomized clinical trials: strengths and limitations. Stat Med 1987; 6: 341e50.
15. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539e58.
16. Figueras J, Llado L, Miro M, Ramos E, Torras J, Fabregat J, Serrano T. Application of fibrin glue sealant after hepatectomy does not seem justified: results of a randomized study in 300 patients. Ann Surg. 2007 Apr; 245(4): 536-42.
17. Kohno H, Nagasue N, Chang YC, et al. Comparison of topical hemostatic agents in elective hepatic resection: a clinical prospective randomized trial. World J Surg. 1992; 16: 966 -970.
18. Liu M, Lui WY: The use of fibrin adhesive for hemostasis after liver resection. Zhonghua Yi Xue Za Zhi (Taipei) 1993; 51: 19-22.
19. Noun R, Elias D, Balladur P, Bismuth H, Parc R, Lasser P, et al.: Fibrin glue effectiveness and tolerance after elective liver resection: a randomized trial. Hepatogastroenterology 1996; 43: 221-224.
20. Uetsuji S, Komada Y, Kwon AH, Imamura A, Takai S, Kamiyama Y. Prevention of pleural effusion after hepatectomy using fibrin sealant. Int Surg. 1994 Apr-Jun; 79(2): 135-7.
21. Chapman WC, Clavien PA, Fung J, Khanna A, Bonham A: Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma: results of a randomized controlled trial. Arch Surg 2000; 135: 1200-1204.
22. Frilling A, Stavrou GA, Mischinger HJ, de Hemptinne B, Rokkjaer M, Klempnauer J, et al.: Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Langenbecks Arch Surg 2005; 390: 114-120.
23. Schwartz M, Madariaga J, Hirose R, Shaver TR, Sher L, Chari R, et al.: Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg 2004; 139: 1148- 1154.
24. Gugenheim J, Bredt LC, Iannelli A: A randomized controlled trial comparing fibrin glue and PlasmaJet on the raw surface of the liver after hepatic resection. Hepatogastroenterology 2011; 58: 922-925.
25. de Boer MT, Klaase JM, Verhoef C, van Dam RM, van Gulik TM, Molenaar IQ, Bosscha K, Dejong CH, van der Jagt EJ, Porte RJ; for the FRESCO Trial Group. Fibrin Sealant for Prevention of Resection Surface-Related Complications After Liver Resection: A Randomized Controlled Trial. Ann Surg. 2012 Aug; 256(2): 229-234.
26. Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH, Dematteo RP. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg. 2009 Apr; 249(4): 617-23.
27. Makino Y, Yamanoi A, Kimoto T, El-Assal ON, Kohno H, Nagasue N. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. Am J Gastroenterol. 2000 May; 95(5): 1294-300.
28. Smyrniotis V, Kostopanagiotou G, Theodoraki K, Tsantoulas D, Contis JC. The role of central venous pressure and type of vascular control in blood loss during major liver resections. Am J Surg. 2004; 187: 398-402.
29. McNally SJ, Revie EJ, Massie LJ, McKeown DW, Parks RW, Garden OJ, Wigmore SJ. Factors in perioperative care that determine blood loss in liver surgery. HPB (Oxford). 2012 Apr; 14(4): 236-41.
30. Berrevoet F, de Hemptinne B: Use of topical hemostatic agents during liver resection. Dig Surg 2007; 24: 288-293.
31. Mosesson MW: Fibrin polymerization and its regulatory role in hemostasis. J Lab Clin Med 1990; 116: 8-17.
32. Capussotti L, Ferrero A, Viganò L, Sgotto E, Muratore A, Polastri R. Bile leakage and liver resection: Where is the risk? Arch Surg. 2006 Jul; 141(7): 690-4.
33. Toti L, Attia M, Manzia TM, Lenci I, Gunson B, Buckels JA, Mirza DF, Mayer AD, Bramhall SR, Wigmore SJ. Reduction in bile leaks following adult split liver transplant using a fibrin-collagen sponge: A pilot study. Dig Liver Dis. 2010 Mar; 42(3): 205-9.
34. Boonstra EA, Adelmeijer J, Verkade HJ, de Boer MT, Porte RJ, Lisman T: Fibrinolytic proteins in human bile accelerate lysis of plasma clots and induce breakdown of fibrin sealants. Ann Surg. 2012 Aug; 256(2): 306-12.
35. Nakajima Y, Shimamura T, Kamiyama T, et al. Control of intraoperative bleeding during liver resection: analysis of a questionnaire sent to 231 Japanese hospitals. Surg Today. 2002; 32: 48-52.
36. Boonstra EA, Molenaar IQ, Porte RJ, et al. Topical haemostatic agents in liver surgery: do we need them? HPB. 2009; 11: 306-310.
37. MedMarket. New wound closures get seal of approval. Available at: http://mediligence. com/blog/2008/02/11/wound-sealant. Accessed September 10, 2012.